News
FDA approves Aimovig for migraine prevention
Aimovig is the first FDA-approved treatment to prevent migraines by blocking the calcitonin gene–related peptide receptor.
News
Certolizumab pegol shows promise for nr-axSpA treatment
C-AXSPAND is the first year-long trial to show positive results vs. placebo in nonradiographic axial spondyloarthritis.
News
Parents smoke less tobacco, more cannabis at home
Secondhand tobacco smoke exposure in childhood is decreasing, while cannabis smoke exposure rises.
News
FDA approves dabrafenib/trametinib for BRAF-positive anaplastic thyroid cancer
Of 23 patients, 57% experienced a partial response and 4% experienced a full response.
News
Very few infants born to HCV-infected mothers receive testing
Despite increasing prevalence of hepatitis C virus infection in pregnant women, infants exposed to the disease are screened at a very low rate.
News
FDA begins priority review of cemiplimab for advanced cutaneous squamous cell carcinoma
Cemiplimab targets the checkpoint inhibitor PD-1.
News
Preterm intervention underused in at-risk women
A retrospective study showed that use of progesterone was limited to less than a third of women with a previous preterm birth or a current short...
News
Successive antiepileptic drug treatments offer diminished chances for seizure freedom
Probability of seizure freedom for 1 year or longer dropped to 12% with second antiepileptic drug regimen.
News
Review: Common gastrointestinal conditions in people living with HIV/AIDS
The two most common gastrointestinal conditions reported by people living with HIV/AIDS are diarrhea and nausea.
News
CMV colitis mortality rates similar in both immunocompetent and immunocompromised patients
Early diagnosis is important for survival, so be alert to many different presentations.
News
Clinical Trial: The Checklist to Prevent MRSA Surgical Site Infections
The VA has developed a new checklist which will be tested in hopes of reducing MRSA surgical site infections.
News
Denosumab indication now includes multiple myeloma, Amgen announces
Denosumab, which is not cleared through the kidneys, offers multiple myeloma patients bone protection with a convenient subcutaneous...
News
Thrombectomy shines in presence of a clinical deficit and imaging mismatch
Less disability, greater functional independence, and less neurologic deterioration was observed for thrombectomy plus standard care.
News
U.S. autism rates edge up from 2014-2016
Increase in ASD prevalence rates are not statistically significant, epidemiologists report.
News
Pertuzumab approved for HER2-positive breast cancer
After a median follow-up period of 45.4 months, an invasive disease event occurred in 7.1% of all patients who received pertuzumab (Perjeta) and...
